Researcher
Karen van Hoeve
- Disciplines:Endocrinology and metabolic diseases, Gastro-enterology and hepatology, Biomarker discovery and evaluation, Drug discovery and development, Medicinal products, Pharmaceutics, Pharmacognosy and phytochemistry, Pharmacology, Pharmacotherapy, Toxicology and toxinology, Other pharmaceutical sciences
Affiliations
- Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Aug 2017 → 10 Aug 2020
Publications
11 - 20 of 25
- INFLIXIMAB SERUM LEVELS DURING INDUCTION PREDICT LONG-TERM ENDOSCOPIC REMISSION IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE.(2020)
Authors: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Marc Ferrante, Séverine Vermeire
Pages: S968 - S968 - Long-term outcome of immunomodulator use in pediatric patients with inflammatory bowel disease(2020)
Authors: Karen van Hoeve, Ilse Hoffman, Marc Ferrante, Séverine Vermeire
Pages: 164 - 172 - Efficacy, pharmacokinetics and immunogenicity is not affected by switching from infliximab originator to a biosimilar in pediatric patients with inflammatory bowel disease.(2019)
Authors: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pages: 317 - 324 - Adequate infliximab exposure during induction predicts remission in paediatric patients with inflammatory bowel disease(2019)
Authors: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pages: 847 - 853 - Outcome of Pregnancies in Female Patients With Inflammatory Bowel Diseases Treated With Vedolizumab(2019)
Authors: Annick Moens, Karen van Hoeve, Peter Bossuyt, Séverine Vermeire, Marc Ferrante
Pages: 12 - 18 - Renal progression factors in young patients with tuberous sclerosis complex: a retrospective cohort study(2018)
Authors: Karen van Hoeve, Liesbeth De Waele, Stéphanie De Rechter, Kathleen Claes, Bert Bammens, Djalila Mekahli
Pages: 2085 - 2093 - Higher Infliximab Trough Levels Are Associated With Better Outcome in Paediatric Patients With Inflammatory Bowel Disease(2018)
Authors: Karen van Hoeve, Erwin Dreesen, Ilse Hoffman, Gert Van Assche, Marc Ferrante, Ann Gils, Séverine Vermeire
Pages: 1316 - 1325 - OUTCOME OF PREGNANCIES IN VEDOLIZUMAB TREATED FEMALE IBD PATIENTS(2018)
Authors: Annick Moens, Karen van Hoeve, Evelien Humblet, Jean-Francois Rahier, Peter Bossuyt, Sophie Dewit, Denis Franchimont, Macken Elisabeth, Jochen Nijs, Annelies Posen, et al.
Pages: S360 - S360 - Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study(2018)
Authors: Karen van Hoeve
Pages: 396 - 403 - Liver involvement in kidney disease and vice versa(2018)
Authors: Karen van Hoeve, Djalila Mekahli, Eva Morava, Elena Levtchenko, Peter Witters
Pages: 957 - 971